INTRODUCTION

These educational Mini Modules™ will review the complications associated with caring for patients with PAH in the context of avoiding and managing PAH-specific health care crises, as well as common emergency/urgent care situations.

Release Date: July 8, 2015
Expiration Date: June 30, 2016

TARGET AUDIENCE

This activity is intended for physicians, physician assistants, nurse practitioners, nurses, and pharmacists who actively treat/manage patients with pulmonary arterial hypertension (PAH).

LEARNING OBJECTIVES

Upon completion of this enduring material, participants should be able to:

METHOD OF PARTICIPATION / HOW TO RECEIVE CREDIT

• There are no fees for participating in and receiving credit for this activity.
• Review the activity objectives and CME/CE information.
• Review all modules associated with this course
• Successfully complete the post-test (80% accuracy)
• Complete the CME/CE evaluation
• The estimated time to complete this activity is 0.5 hour.
• Upon successful completion, your CME/CNE certificate will be available to print the certificate for your records. CPE credit will be submitted to the University of Florida and posted to the CPE monitor

JOINT PROVIDERSHIP

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Nebraska Medical Center, Center for Continuing Education, the University of Nebraska Medical Center College of Nursing Continuing Nursing Education, the University of Florida College of Pharmacy, and Practice Point Communications.

ACCREDITATION STATEMENTS

PHYSICIANS
The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Nebraska Medical Center, Center for Continuing Education designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSES
The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity is provided for 0.5 contact hours under ANCC criteria.

PHARMACISTS
The University of Florida College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education (UAN # ).

This activity is accredited for 0.5 hour of continuing pharmacy education (CPE) credit. The University of Florida College of Pharmacy will report all credit to CPE Monitor within 60 working days of course completion after receiving evidence of successful completion of the course.

Participation in the entire knowledge based activity is required to obtain a certificate. This activity is being presented without bias and with commercial support.

RESOLUTION OF CONFLICT OF INTEREST

In accordance with the ACCME, ANCC and ACPE Standards for Commercial Support of CME, the University of Nebraska Medical Center, Center for Continuing Education, College of Nursing Continuing Nursing Education, the University of Florida College of Pharmacy, and Practice Point Communications will implement mechanisms, prior to the planning and implementation of this CME/CE activity, to identify and resolve conflicts of interest for all individuals in a position to control content of this CME/CE activity.

DISCLOSURE

All planners and faculty participating in continuing education activities provided by the University of Nebraska Medical Center, Center for Continuing Education, University of Nebraska Medical Center, College of Nursing Continuing Nursing Education, and the University of Florida College of Pharmacy are expected to disclose to the audience any support or relationship(s) with providers of commercial products and/or devices discussed in this activity and/or with any commercial supporters of the activity. A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. Disclosure of these commitments and/or relationships is included in activity materials so that participants in the activity may formulate their own judgments in interpreting its content and evaluating its recommendations. In addition, all faculty are expected to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in their presentation. The planners and faculty have been advised that this activity must be free from commercial bias, and based upon all the available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.

All materials are included with the permission of the authors. The opinions expressed are those of the authors and are not to be construed as those of the University of Nebraska Medical Center, Center for Continuing Education or the University of Nebraska Medical Center, College of Nursing Continuing Nursing Education, and the University of Florida College of Pharmacy.

The following indicates the disclosure declaration information and the nature of those commercial relationships.

DISCLOSURES

The speakers and planning committee members listed below have stated they have no significant relationships to disclose.
Catherine Bevil, EdD, RN
Heidi Keeler, PhD, RN
Austin Thompson, MD
Lois Colburn
Megan Murphy-Menezes, PharmD, MSCR
Chris Fleming
Christa Master

The following speakers and/or planners have stated that they have the following financial relationship(s) and they have agreed to see that all information they planned and/or present is done so fairly and without bias:

FACULTY DISCLOSURES

James R. Seibold, MD
Grant/research support: Actelion, Gilead Sciences, Pfizer, United Therapeutics
Consultant: Gilead Sciences, Pfizer, United Therapeutics, Eiccose, Eiger, DART, Bayer, Boehringer-Ingelheim, BiogenIdec
Speaker's bureau: United Therapeutics
Stock shareholder: Sapientia, Pacific Therapeutics
Other financial or material support: None

Virginia D. Steen, MD
Grant/research support: Actelion, Gilead Sciences, United Therapeutics, Roche, Sanofi, CSL Behring
Consultant: Bristol-Myers Squibb, Gilead Sciences, Sanofi, United Therapeutics
Speaker's bureau: Actelion, Gilead Sciences
Stock shareholder: None
Other financial or material support: None

DISCLAIMER

The University of Nebraska Medical Center, Center for Continuing Education, College of Nursing Continuing Nursing Education, University of Florida College of Pharmacy, and Practice Point Communications present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The University of Nebraska Medical Center, Center for Continuing Education, College of Nursing Continuing Nursing Education, the University of Florida College of Pharmacy, Practice Point Communications, and Gilead Sciences Medical Affairs assume no liability for the information herein. Accredited status as a continuing nursing education provider refers only to the University of Nebraska Medical Center College of Nursing Continuing Nursing Education continuing education activities, and does not imply UNMC or American Nurses Credentialing Center Commission on Accreditation endorsement of any commercial supporters.

PRIVACY POLICY

The University of Nebraska Medical Center, Center for Continuing Education, College of Nursing Continuing Nursing Education, the University of Florida College of Pharmacy, and Practice Point Communications protects the privacy of personal and other information regarding participants and educational collaborators. The University of Nebraska Medical Center, Center for Continuing Education, College of Nursing Continuing Nursing Education, University of Florida College of Pharmacy, and Practice Point Communications will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the ACCME, ANCC, or ACPE.

The University of Nebraska Medical Center, Center for Continuing Education, College of Nursing Continuing Nursing Education, the University of Florida College of Pharmacy, and Practice Point Communications maintain physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse or alteration of information that we have collected from you.

COPYRIGHT INFORMATION

Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software (“Materials”) found on the site subject to the following terms, conditions, and exceptions:

The Materials are to be used solely for personal, noncommercial, informational and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.

Materials may not be published, uploaded, posted, transmitted (other than as set forth herin), without prior written permission.

HARDWARE/SOFTWARE REQUIREMENTS

• Hardware: A minimum of 512MB of RAM and a Pentium IV CPU for Intel-based hardware & PowerPC G4 or above for MAC.
• Graphics/Monitor: A color monitor capable of a minimum of 1024 x 768 pixel resolution
• Network: An Internet connection with 1Mbps available download & 256kbps bandwidth

• Windows XP or above running Internet Explorer 7 (service pack 2) or above.
• MAC OSX 10.5 (Leopard) or above running Safari 5.1 or above, or any version of Chrome, Firefox or Opera published in the last two years.
• A recent version of a Linux distribution or FreeBSD running Chrome v13, Opera 11.5, Firefox 5.0.1, or Epiphany 3.0.4 or above

• Any Apple iPad or iPad Mini running IOS 5 or above.
• Most high-performance Android tablets such as the Kindle Fire or Samsung Galaxy S

COMMERCIAL SUPPORT ACKNOWLEDGMENT